Matrix metalloproteinase-7 (MMP-7) has shown promise in diagnosing BA (Jiang et al., 2019; Yang et al., 2018), and metabolomics-based identification of blood biomarkers holds potential for early screening (Xiao et al., 2022). This evidence concerns the gene MMP7 and breast angiosarcoma.